Carbone, Carmine, Geny Piro, Anna Tamburrino, MinaMaria Mihaela, Silvia Zanini, Giampaolo Tortora, and Davide Melisi. “TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance”. JOP. Journal of the Pancreas 14, no. 5S (September 15, 2013): 562. Accessed May 5, 2024. http://www.serena.unina.it/index.php/jop/article/view/1866.